Healio

Vascular closure device receives FDA approval for venous indication

The FDA has approved a new indication for a vascular closure device that enables its use for the closure of femoral arterial and femoral venous access sites, according to a press release. The MynxGrip ...
Yahoo Finance

Vascular Closure Device Market Size Projected to Grow to USD 3.03 Billion by 2030, Fuelled by Cardiovascular Disease Prevalence and Minimally Invasive Trends - The Insight Partners

US & Canada, April 03, 2025 (GLOBE NEWSWIRE) -- US & Canada, Apr, 01, 2025 (GlobeNewswire) -- According to a comprehensive report from The Insight Partners, “Vascular Closure Device Market Size and ...
Yahoo Finance

Vascular Closure Device Market Share Worth $2.80 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to ...
Mena FN

Vascular Closure Devices Market Set To Reach USD 3.25 Billion By 2032, Driven By Rising Interventional Procedures And Device Advancements SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider Highlights the Growth of the U.S. Vascular Closure Devices Market-Expected to Surpass USD 0.84 Billion by 2032 Amid Increasing Cardiovascular Interventions ...
Healio

Vascular closure devices: Use reasonable in many cases; definitive evidence needed

HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better outcomes than manual compression, their use appears appropriate in most procedures with ...
TCTMD

AccessClosure Launches the Next-Generation Mynx Ace™ Vascular Closure Device at Annual ACC Meeting

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...
TCTMD

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

In general, use of a vascular closure device after transfemoral percutaneous coronary intervention (PCI) decreases the risk of vascular complications, according to a large registry study of real-world ...
Business Wire

Vivasure Medical Announces Development of Sutureless Venous Closure Device for Use in Percutaneous Transcatheter Procedures

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...
PharmiWeb

Vascular Closure Device Market Insights: Unraveling Key Takeaways for Healthcare Professionals

The Vascular Closure Device Market is experiencing a dynamic surge driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. These devices play a pivotal ...
FierceBiotech

Metal-based bioresorbable vascular closure device obtains CE mark

Transluminal Technologies last week announced that it has received a CE mark for the bioresorbable Velox CD Vascular Closure Device for hemostasis, or stopping bleeding, in the thigh's femoral artery ...
Mena FN

Vascular Closure Device Market Size Projected To Grow To USD 3.03 Billion By 2030, Fuelled By Cardiovascular Disease Prevalence And Minimally Invasive Trends - The Insight Partners

(MENAFN- GlobeNewsWire - Nasdaq) The global vascular closure device market share is projected to grow from USD 1.73 billion in 2022 to USD 3.03 billion by 2030, driven by the increasing prevalence of ...